
Sign up to save your podcasts
Or


Introducing S5:E2 Drug Affordability: The High Cost of Healing from Unseen Upside: Investments Beyond Their Returns.
Follow the show: Unseen Upside: Investments Beyond Their Returns
Prescription drug prices in the United States are 2.78 times higher than in other developed countries, but why?
We untangle the barriers surrounding drug affordability and find out why accessing life-saving medications is costly to so many. Joined by experts, advocates, and one Cystic Fibrosis patient relying on expensive medication to live, we examine the complex factors contributing to the high costs of drugs, from research and development to pricing strategies and supply chain dynamics. We also investigate potential solutions to improve access and affordability without compromising on drug innovation.
Guests include:
Unseen Upside: Investments Beyond Their Returns is developed in partnership with PRX, an award-winning podcast media company.
Cambridge Associates is a global investment firm that works with endowments, foundations, healthcare systems, pension plans, and private clients to implement and manage custom investment portfolios that aim to generate outperformance and maximize their impact on the world. Cambridge Associates delivers a range of portfolio management services, including outsourced CIO, non-discretionary portfolio management, staff extension, and asset class mandates.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
By PodcastOne / Carolla Digital4.5
3648336,483 ratings
Introducing S5:E2 Drug Affordability: The High Cost of Healing from Unseen Upside: Investments Beyond Their Returns.
Follow the show: Unseen Upside: Investments Beyond Their Returns
Prescription drug prices in the United States are 2.78 times higher than in other developed countries, but why?
We untangle the barriers surrounding drug affordability and find out why accessing life-saving medications is costly to so many. Joined by experts, advocates, and one Cystic Fibrosis patient relying on expensive medication to live, we examine the complex factors contributing to the high costs of drugs, from research and development to pricing strategies and supply chain dynamics. We also investigate potential solutions to improve access and affordability without compromising on drug innovation.
Guests include:
Unseen Upside: Investments Beyond Their Returns is developed in partnership with PRX, an award-winning podcast media company.
Cambridge Associates is a global investment firm that works with endowments, foundations, healthcare systems, pension plans, and private clients to implement and manage custom investment portfolios that aim to generate outperformance and maximize their impact on the world. Cambridge Associates delivers a range of portfolio management services, including outsourced CIO, non-discretionary portfolio management, staff extension, and asset class mandates.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].

228,897 Listeners

14,237 Listeners

41,169 Listeners

8,755 Listeners

6,554 Listeners

4,181 Listeners

3,598 Listeners

1,155 Listeners

4,892 Listeners

12,874 Listeners

2,153 Listeners

875 Listeners

40,385 Listeners

8,963 Listeners

16,898 Listeners